Dermatological Manifestations in Cirrhotic Patients: A Comprehensive Review

Main Article Content

Hiebda Sofía Martínez Jiménez

Abstract

Cirrhosis of the liver is a complex and debilitating condition characterized by the progressive deterioration of hepatic function due to chronic liver disease. While hepatic dysfunction remains central to its pathophysiology, cirrhosis often presents with a myriad of extrinsic manifestations that extend beyond the hepatobiliary system. Dermatological manifestations in cirrhotic patients are a frequently encountered yet underappreciated facet of this multisystem disorder. These cutaneous signs can serve as invaluable clinical indicators, aiding in both the early detection and management of cirrhosis. This comprehensive review article aims to elucidate the diverse dermatological presentations associated with cirrhosis, shedding light on their underlying mechanisms, clinical relevance, and diagnostic significance. We delve into the pathophysiological basis of these dermatological manifestations, encompassing conditions such as spider angiomas, palmar erythema, pruritus, and jaundice-associated changes, among others. Furthermore, we explore the intricate interplay between liver dysfunction, immune dysregulation, and the skin, providing a holistic perspective on the dermatological dimension of cirrhosis. Through this comprehensive analysis, we aspire to enhance clinicians' awareness and understanding of these dermatological cues, ultimately contributing to improved patient care, early intervention, and a deeper appreciation of the intricate relationship between the liver and the integumentary system.

Article Details

How to Cite
Hiebda Sofía Martínez Jiménez. (2023). Dermatological Manifestations in Cirrhotic Patients: A Comprehensive Review. International Journal of Medical Science and Clinical Research Studies, 3(12), 3073–3077. https://doi.org/10.47191/ijmscrs/v3-i12-29
Section
Articles

References

I. Hazin R, Abu-Rajab Tamimi TI, Abuzetun JY, et al.. Recognizing and treating cutaneous signs of liver disease. Cleve Clin J Med. 2009;76(10):599–606.

II. Asrani SK, Devarbhavi H, Eaton J, et al.. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171.

III. Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77.

IV. Tapper EB, Parikh ND.. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817.

V. Beste LA, Leipertz SL, Green PK, et al.. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Gastroenterology. 2015;149(6):1471–1482.

VI. Zou B, Yeo YH, Jeong D, et al.. A nationwide study of inpatient admissions, mortality, and costs for patients with cirrhosis from 2005 to 2015 in the USA. Dig Dis Sci. 2020;65(5):1520–1528.

VII. Møller S, Bendtsen F.. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 2018;38(4):570–580.

VIII. Okumura H, Aramaki T, Katsuta Y, et al.. Regional differences in peripheral circulation between upper and lower extremity in patients with cirrhosis. Scand J Gastroenterol. 1990;25(9):883–889.

IX. Steele JD, Dillon JF, Plevris JN, et al.. Hand skin temperature changes in patients with chronic liver disease. J Hepatol. 1994;21(6):927–933.

X. Serrao R, Zirwas M, English JC.. Palmar erythema. Am J Clin Dermatol. 2007;8(6):347–356.

XI. Amoroso S, Pastore S, Tommasini A, et al.. Palmar erythema: a diagnostic clue of juvenile dermatomyositis. J Paediatr Child Health. 2020;56(7):1159.

XII. Li CP, Lee FY, Hwang SJ, et al.. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol. 1999;94(2):502–507.

XIII. Li CP, Lee FY, Hwang SJ, et al.. Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol. 1999;34(5):520–523.

Most read articles by the same author(s)